Most Down Articles

    Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

    All
    Please wait a minute...
    For Selected: Toggle Thumbnails
    Chinese interpretation of Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition) and Ruijin clinical practice
    YAN Chao, LU Sheng, YAN Min, ZHU Zhenggang
    Journal of Surgery Concepts & Practice    2023, 28 (04): 326-354.   DOI: 10.16139/j.1007-9610.2023.04.010
    Abstract1466)   HTML33)    PDF(pc) (4954KB)(3948)       Save

    “Japanese Gastric Cancer Treatment Guidelines” have been important guidelines for the treatment of gastric cancer in Japan and worldwide. The English version “Japanese Gastric Cancer Treatment Guidelines 2021 (6th Edition)” published in January 2023 consists of two parts. The first part includes diagnostic and treatment methods, such as surgery, endoscopic resection, chemotherapy, follow-up. The second part addresses clinical issues, including recommendations and explanations for clinical hot topics. This article will provide a Chinese interpretation of the guidelines and briefly introduce our hospital's clinical practice in the diagnosis and treatment of gastric cancer.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Interpretation of the 2022 edition of “guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis in China”
    XU Bojin, PENG Wenfang, HUANG Shan
    Journal of Surgery Concepts & Practice    2023, 28 (06): 512-519.   DOI: 10.16139/j.1007-9610.2023.06.05
    Abstract1270)   HTML8)    PDF(pc) (889KB)(3506)       Save

    “Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis in China” (2022) (referred to as the “guidelines”) was officially published in August 2022 in the Chinese Journal of Endocrine Metabolism. These guidelines have been extensively updated from the 2007 version, with 15 sections covering the etiology, clinical manifestations, diagnosis, evaluation, and treatment of hyperthyroidism, as well as the management of specific types of thyrotoxicosis. The new version guidelines proposed 107 recommended opinions supported by stronger evidence, offering comprehensive and reliable guidance for clinical doctors and medical professionals dealing with thyrotoxicosis. This article aimed to extract the key points and recommended strategies from the guidelines to help clinical doctors better understand and apply the latest guiding principles.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Advances in surgical treatment of hepatocellular carcinoma
    HUANG Jiwei, QIU Guoteng, ZENG Yong
    Journal of Surgery Concepts & Practice    2022, 27 (02): 113-118.   DOI: 10.16139/j.1007-9610.2022.02.005
    Abstract268)   HTML2)    PDF(pc) (554KB)(2551)       Save
    Reference | Related Articles | Metrics | Comments0
    The fifth edition of WHO classification of digestive system tumors: update and progress on biliary system tumors
    LUO Fangxiu, MA Qianchen, YUAN Fei
    Journal of Surgery Concepts & Practice    2023, 28 (02): 124-131.   DOI: 10.16139/j.1007-9610.2023.02.08
    Abstract992)   HTML20)    PDF(pc) (3365KB)(2473)       Save

    Overall, there was little change in biliary system tumors of the 5th edition of WHO classification of digestive system tumors after update. The three-tiered classification of biliary intraepithelial neoplasia changed to two-tiered system: high-grade and low-grade, in the section of benign tumors and precancerous lesions. And both intracholecystic and intraductal papillary tumors associated with invasive carcinoma were added. The classification of intrahepatic bile duct tumors introduced parts of bile duct adenoma and bile duct adenofibroma, which were mentioned previously in the differential diagnosis with bile duct carcinoma. Intrahepatic cholangiocarcinoma was divided into small bile duct subtype and large bile duct subtype in the 5th edition of WHO classification, and the names of cholangiocellular carcinoma and cholangiole cell carcinoma were no longer recommended to use. Extrahepatic cholangiocarcinoma was listed as a separate part for the first time, including squamous cell carcinoma, adenosquamous carcinoma and undifferentiated carcinoma in addition to common histological types. Some new contents of molecular pathology in the 5th edition of WHO classification were added, which provided the basis for precise classification and diagnosis of tumors in biliary system.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Development and prospects of ERCP in China
    LI Wen
    Journal of Surgery Concepts & Practice    2023, 28 (04): 279-282.   DOI: 10.16139/j.1007-9610.2023.04.001
    Abstract918)   HTML15)    PDF(pc) (838KB)(1612)       Save

    Endoscopic retrograde cholangio-pancreatography (ERCP) is an interventional endoscopic technique aimed at the diagnoses and treatment of biliary and pancreatic diseases under the guidance of endoscopy and X-ray ima-ging. ERCP was introduced into China from the 1970s. In the 1990s, ERCP was gradually popularized and applied in China with the development of medical technique and improvement of equipment, more medical institutions started to carry out ERCP. After 2000, ERCP technology and equipment were further upgraded and improved in China. Many secondary and tertiary hospitals began to establish the ERCP centers. Meanwhile, workshops and training also facilitated the teaching and practice of ERCP and cultivated more professionals of ERCP. In recent years, the technical level of ERCP in China has been continuously improved, and technologies and equipments are constantly updated and iterated. Currently, ERCP has become one of important techniques in the endoscopic field, playing an important role in the diagnosis and treatment of biliary and pancreatic diseases. The vigorous development of ERCP in China is attributed to the advancement of medical science, the improvement of technology and the efforts of generations of ERCP specialists.

    Reference | Related Articles | Metrics | Comments0
    Value of proton and heavy ion radiotherapy in treatment of retroperitoneal sarcoma
    WANG Zheng, BAO Cihang, JIANG Guoliang
    Journal of Surgery Concepts & Practice    2022, 27 (06): 506-510.   DOI: 10.16139/j.1007-9610.2022.06.05
    Abstract431)   HTML14)    PDF(pc) (826KB)(1591)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Interpretation of the 5th edition WHO classification and staging of digestive system tumors: colorectal tumors
    YU Yingyan
    Journal of Surgery Concepts & Practice    2021, 26 (04): 312-317.   DOI: 10.16139/j.1007-9610.2021.04.008
    Abstract1709)   HTML80)    PDF(pc) (589KB)(1265)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Intrahepatic cholangiocarcinoma: interpretation of expert consensus and guideline from domestic and abroad
    WANG Chong, CHENG Shi
    Journal of Surgery Concepts & Practice    2021, 26 (02): 124-129.   DOI: 10.16139/j.1007-9610.2021.02.008
    Abstract504)   HTML21)    PDF(pc) (642KB)(1103)       Save
    Reference | Related Articles | Metrics | Comments0
    Progress of minimally invasive thyroid surgery
    LI Jiamin, KANG Jie, WU Bo, FAN Youben
    Journal of Surgery Concepts & Practice    2023, 28 (03): 273-277.   DOI: 10.16139/j.1007-9610.2023.03.016
    Abstract315)   HTML7)    PDF(pc) (817KB)(955)       Save

    The incidence of thyroid cancer has increased in recent years. The desire for aesthetics and quality of life, combined with the development of energy devices and robotics make surgeons introduction of minimally invasive procedures both more refined and difficult techniques, resulting less painful and better aesthetic results. Thyroidectomy has been expanded to include minimally invasive video-assisted thyroidectomy, multi-approach to endoscopic thyroidectomy, thermal ablation, chemical ablation and robot-assisted thyroidectomy.

    Reference | Related Articles | Metrics | Comments0
    Interpretation of the 5th edition WHO classificaion and staging of tumors of digestive system: gastric tumors
    YU Yingyan, ZHU Zhenggang
    Journal of Surgery Concepts & Practice    2020, 25 (03): 207-210.   DOI: 10.16139/j.1007-9610.2020.03.007
    Abstract2016)   HTML102)    PDF(pc) (439KB)(942)       Save
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    The current status of thermal ablation in the treatment of papillary thyroid microcarcinoma
    LIN Tingyu, ZHAO Yanna, FEI Jian
    Journal of Surgery Concepts & Practice    2023, 28 (05): 477-482.   DOI: 10.16139/j.1007-9610.2023.05.14
    Abstract215)   HTML4)    PDF(pc) (865KB)(813)       Save

    Thermal ablations are rapidly developing techniques for minimally invasive treatment, including laser ablation, radiofrequency ablation, and microwave ablation. Such remarkable success has been achieved in treatment malignant neoplasms, for instance, hepatocellular carcinoma and renal cell adenocarcinoma. In recent years, the practice has been gradually adopted into the treatment of papillary thyroid microcarcinoma (PTMC). Many reports have stated that thermal ablations have distinctive advantages over traditional thyroidectomy owing to its efficacy and safety for treatment primary PTMC, meanwhile there are many controversial issues which hotly debated regarding to first-line treatments. Recently, indications and contraindications of thermal ablation for PTMC have been successively proposed by guidelines and consensuses. Many follow-up reports related to thermal ablation in the treatment of PTMC have been reported in clinical practice as well. In this review, we summarized the principles, indications and contraindications, and the efficacy and safety of thermal ablation in the treatment of PTMC, and compared it with traditional surgery.

    Reference | Related Articles | Metrics | Comments0
    Summary and prospect of perioperative comprehensive treatment for gastric cancer in China
    LIU Wentao, LIU Fukun
    Journal of Surgery Concepts & Practice    2023, 28 (01): 36-41.   DOI: 10.16139/j.1007-9610.2023.01.06
    Abstract454)   HTML10)    PDF(pc) (860KB)(580)       Save

    Most of the patients with gastric cancer in China have been at the middle and advanced stages during diagnostic and treatment with poor prognosis overall. Perioperative radiotherapy, chemotherapy, immune therapy and other comprehensive treatment methods for gastric cancer patients preoperative and intraoperation may reduce tumor staging, increase the rate of surgical resection and prolong the time of patient survival. Perioperative comprehensive treatment has developed more than 30 years in China. Many results from relevant research were gotten combined with laying down the consensus and guidelines, and applied to clinic in recent years. With the emergence and development of new technologies and new strategies for comprehensive treatment, perioperative comprehensive treatment and conversion therapy will improve at much extent the rate of survival for gastric cancer patients in China.

    Reference | Related Articles | Metrics | Comments0
    Exosome in gastric cancer: research and perspective
    FAN Qingquan, SONG Xiaoling, GU Jun
    Journal of Surgery Concepts & Practice    2023, 28 (02): 177-180.   DOI: 10.16139/j.1007-9610.2023.02.17
    Abstract365)   HTML2)    PDF(pc) (927KB)(568)       Save

    Exosomes are extracellular vesicles of 40-150 nm in size, which are widely distributed in various body fluids. Gastric cancer is the most common digestive tract malignancy in China. Exosomes are involved in the malignant evolution of gastric cancer in multiple ways including growth, progression, metastasis and microenvironment of tumor. Exosomes might be a non-invasive biological marker for early diagnosis of gastric cancer and have also shown potential as drug carriers in the treatment of gastric cancer. This article reviews recent research on exosomes in the pathogenesis and treatment of gastric cancer.

    Reference | Related Articles | Metrics | Comments0
    Stage on development of pathophysiology of gallbladder stone and personalized diagnosis and treatment
    ZHENG Yamin, GU Liguo, XU Chen
    Journal of Surgery Concepts & Practice    2023, 28 (02): 94-99.   DOI: 10.16139/j.1007-9610.2023.02.02
    Abstract561)   HTML10)    PDF(pc) (799KB)(567)       Save

    Gallbladder stone (GS) is a common disease. There are no obvious symptoms at early stage for the patient with GS. Obstruction will cause acute cholecystitis. Secondary obstructive cholangitis of GS, biliary pancreatitis, gallbladder cancer due to GS would be serious. Many guidelines and consensuses have been published in the world and from many professional organizations, promoting the normative diagnosis and treatment of GS. However, there are still a lot of controversial issues. Currenly, there is a lack of study on the whole course of GS with large samples. Prevention and early diagnosis with treatment of GS are neglected. It results in insufficient personalized diagnosis and treatment. In order to have the prevention, diagnosis, treatment, prognosis and follow-up which are carried out better, the authors divided the course of GS into four stages according to the pathophysiological characteristics of the occurrence, development and outcome of GS. There are: ①stage of stone forming; ②asymptomatic period without obstruction; ③inflammation and infection stage, inclu-ding obstructive inflammation, pyogenic gangrene, perforation abscess; ④stage of secondary lesions, including abnormal gallbladder morphology and function, GS shift, gallbladder carcinoma. According to the pathophysiological staging, it is beneficial to the personalized diagnosis and treatment based on the standard management for the patients who can benefit more.

    Reference | Related Articles | Metrics | Comments0
    Consensus and controversy in postoperative thyroid stimulating hormone suppression therapy for differentiated thyroid carcinoma
    LIU Jie, XIAN Keyao
    Journal of Surgery Concepts & Practice    2023, 28 (06): 507-511.   DOI: 10.16139/j.1007-9610.2023.06.04
    Abstract181)   HTML4)    PDF(pc) (765KB)(553)       Save

    Differentiated thyroid carcinoma (DTC) is the most common thyroid carcinoma, with a generally favorable prognosis for most patients. At present, Surgery, 131I and thyroid stimulating hormone (TSH) suppression are the main therapeutic means among which, TSH suppression therapy plays an important role in the postoperative management of DTC patients, which has the effect of decreasing the risk of recurrence, slowing down the progression of the disease, and improving long-term survival. However, excessive TSH suppression can increase the risk of adverse events in the cardiovascular and skeletal systems. Currently, there is ongoing debate regarding the optimal target range for serum TSH suppression in patients of all types. In clinical practice, it is important to carefully balance the benefits and potential risks of TSH suppression, and to personalize the target range for serum TSH based on dynamic assessments during patient follow-up. This article aimed to discuss the intensity, benefits, and risks of TSH suppression after surgery for DTC patients, as well as the current controversies about this topic.

    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Controversy over the medial border of lymph node dissection during CME/D3 surgery of right colon cancer
    SUN Yueming, ZHANG Dongsheng
    Journal of Surgery Concepts & Practice    2023, 28 (03): 202-207.   DOI: 10.16139/j.1007-9610.2023.03.005
    Abstract609)   HTML7)    PDF(pc) (929KB)(551)       Save

    Radical surgery is the most important treatment for colon cancer. The development and application of complete mesentery excision (CME)/D3 lymph node dissection has promoted the standardization of surgical techniques for colon cancer. Right colon cancer surgery is relatively complicated, and is a research hotspot currently. The issues involved the range of lymph node dissection, the range of bowel resection, and the method of bowel reconstruction. The medial border of lymph node dissection for right colon cancer is one of the controversies. The left side of the superior mesenteric vein is generally considered to be the medial border of CME/D3 dissection in right colon cancer surgery. However, with the in-depth development of related research, some scholars believed that the left side of the superior mesenteric artery should be used as the medial border for lymph node dissection. This approach is more consistent with the principle of CME, and can achieve complete lymph node dissection. However, its clinical significance still needs to be evaluated with further research. This article discusses the selection of medial border of lymph node dissection for right colon cancer, hoping to provide reference for clinical practice.

    Reference | Related Articles | Metrics | Comments0
    Association between RET genotype and disease phenotype in patients with hereditary medullary thyroid carcinoma
    ZHANG Gang, ZHANG Zhe, ZHANG Shu, LI Zhirong, TIAN Wuguo, HUANG Qi, WANG Lingli, XU Yan
    Journal of Surgery Concepts & Practice    2021, 26 (06): 522-527.   DOI: 10.16139/j.1007-9610.2021.06.013
    Abstract350)   HTML1)    PDF(pc) (556KB)(549)       Save
    Objective To investigate the association between RET genotype and disease phenotype in the patients with hereditary medullary thyroid carcinoma (HMTC). Methods A total of 13 patients diagnosed as HMTC and undergoing surgical treatment for thyroid carcinoma in this hospital from March 2015 to September 2019 were analyzed retrospectively with follow-up cutoff at September 2021. The patient risk stratification was performed according to American Thyroid Association (ATA) guidelines. The association between RET genotype and disease phenotype including biochemical results, TNM stage, both biochemical [normal serum calcitonin(CT)] cure and clinical cure was analyzed. Results There were 1 (7.69%) case, 6(46.15%) cases, and 6(46.15%) cases with the highest risk mutation (RET M918T), high-risk mutation (RET C634Y and C634S), and moderate-risk mutation (RET C618G and C611Y), respectively. One case with the highest risk mutation was at TNM stage Ⅳ. There were 4 cases (66.67%) at stageⅠand 2 cases (33.33%) at stage Ⅲ among 6 cases with high-risk mutation. For 6 cases with moderate-risk mutation, stage Ⅰ and stage Ⅱ had 1 case(16.67%) respectively, and stage Ⅲ and stage Ⅳ with 3 cases (50%) and 1 case (16.67%) respectively. The highest preoperative CT and carcinoembryonic antigen were detected in 1 case with highest risk mutations (20 000 ng/L, 831.8 μg/L), and those lower in 6 cases with moderate-risk mutations (1 221.4 ng/L, 62.3 μg/L). The lowest of them were in 6 cases with high-risk mutations (537.7 ng/L, 41.7 μg/L). Similarly, both clinical cure rate and biochemical cure rate were found poorer in the cases with the highest risk mutation, and better in the case with high-risk mutation, and less better in the cases with moderate-risk mutation. Conclusions RET gene could be associated with HMTC risk of ATA. The patients of RET genotype with high-risk mutations would have higher clinical cure rate and biochemical cure rate than the cases with moderate-risk mutations.
    Table and Figures | Reference | Related Articles | Metrics | Comments0
    Current status of minimally invasive surgery of gastroesophageal reflux disease
    Aikebaier·Aili , Yusujiang·Tusuntuoheti , Kelimu·Abudureyimu
    Journal of Surgery Concepts & Practice    2023, 28 (03): 208-214.   DOI: 10.16139/j.1007-9610.2023.03.006
    Abstract209)   HTML6)    PDF(pc) (865KB)(523)       Save

    Gastroesophageal reflux disease (GERD) is one of the common gastrointestinal diseases. The treatment options for GERD includes lifestyle changes, medication, and surgery. With the development of surgical technology, minimally invasive surgery has become more and more widely used in clinical practice due to its advantages such as less trauma and rapid postoperative recovery. Laparoscopic fundoplication is the standard surgical treatment for GERD. Due to the postoperative complications of laparoscopic fundoplication, a variety of new alternative minimally invasive surgery methods, which are expected to provide new treatment options for GERD patients, have emerged recently. Surgical minimally invasive procedures include magnetic sphincter augmentation (MSA), bariatric surgery, and lower esophageal sphincter electric stimulating therapy (LES-EST). Endoscopic minimally invasive procedures include transoral incisionless fundoplication (TIF), Stretta radiofrequency ablation, and anti-reflux mucosectomy (ARMS). This article mainly describes the current status of minimally invasive surgical treatment of GERD.

    Reference | Related Articles | Metrics | Comments0
    Progress of study on gallbladder adenomyomatosis: pathogenesis, diagnosis and treatment
    CHEN Xuanwu, YANG Chuanyu, JIANG Minjie, DU Weidong
    Journal of Surgery Concepts & Practice    2022, 27 (01): 87-90.   DOI: 10.16139/j.1007-9610.2022.01.020
    Abstract1045)   HTML45)    PDF(pc) (407KB)(516)       Save

    Gallbladder adenomyomatosis(GA) is a relatively rare benign disease of unknown both etiology and pathogenesis. The development of imaging technology improved diagnosis of GA. Some believed that GA related to gallbladder cancer, which is still controversial. Preventive cholecystectomy was proposed to treat GA and some GA could be followed up. Therefore no consensus of treatment of GA is present now. Etiology, pathogenesis, diagnosis and treatment of GA were included in this article.

    Reference | Related Articles | Metrics | Comments0
    Conversion therapy for intrahepatic cholangiocarcinoma: status and perspectives
    FANG Cheng, XIA Yong, WANG Kui, SHEN Feng
    Journal of Surgery Concepts & Practice    2022, 27 (02): 107-112.   DOI: 10.16139/j.1007-9610.2022.02.004
    Abstract306)   HTML7)    PDF(pc) (585KB)(499)       Save
    Reference | Related Articles | Metrics | Comments0